Author

H. Kumalo

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Metabolic Milieu and Susceptibility: The Combined Benefits of Targeting AMPK and ACE2 for Metabolic Disorders and COVID-19

The convergence of metabolic dysfunction and infectious diseases has become increasingly evident, particularly during the COVID-19 pandemic. AMP-activated protein kinase (AMPK) and angiotensin-converting enzyme 2 (ACE2) emerge as pivotal molecular regulators linking metabolic homeostasis, endothelial integrity, immune...

F. Tata, M. B. Nxumalo, Nosipho Ntanzi et al. · International Journal of Mol... · 0 citations

Open access Sep 2026

An interpretable consensus pipeline for candidate dopamine D2 receptor ligands

Machine learning accelerates GPCR ligand discovery but often lacks interpretability and struggles to generalise to structurally novel chemical space. We present an integrated framework combining ensemble learning, SHAP interpretability, and complementary structure-based analyses to prioritise putative candidates for th...

Sphamandla E. Mtambo, H. Kumalo, C. Ssemakalu · In Silico Pharmacology · 0 citations